Paper268489
n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells.
Riggs MG and 3 others. Nature, 1977. Cited by 557 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. n-Butyrate causes histone modification in HeLa and Friend erythroleukaemia cells. Papers, record 268489. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/268489
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Butyrates | Major topic |
| Histones | Major topic |
| Acetylation | |
| Cell Differentiation | |
| Cell Line | |
| Friend murine leukemia virus | |
| HeLa Cells | |
| Leukemia, Erythroblastic, Acute | |
| Neoplasm Proteins | |
| Time Factors |
Source PubMed
Cited by219
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 557 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,651,418 | Profiling the pancreatic cancer secretome with metabolic glycoengineering. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41651418 | PubMed |
| 41,303,712 | Non-Histone Lysine Modifications in Tumor Microenvironment: Mechanisms and Therapeutic Opportunities. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41303712 | PubMed |
| 41,106,207 | Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic ductal adenocarcinoma. | Drug Resist Updat | 2026 | https://conductscience.org/library/papers/41106207 | PubMed |
| 41,049,070 | The Role of Butyric Acid and Microorganisms in Chronic Inflammatory Diseases and Microbiome-Based Therapeutics. | J Inflamm Res | 2025 | https://conductscience.org/library/papers/41049070 | PubMed |
| 40,283,998 | Histone Deacetylase Inhibitors Promote the Anticancer Activity of Cisplatin: Mechanisms and Potential. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40283998 | PubMed |
| 38,585,101 | Short-Chain Fatty Acid (SCFA) as a Connecting Link between Microbiota and Gut-Lung Axis-A Potential Therapeutic Intervention to Improve Lung Health. | ACS Omega | 2024 | https://conductscience.org/library/papers/38585101 | PubMed |
| 38,434,086 | The role of short-chain fatty acids in central nervous system diseases: A bibliometric and visualized analysis with future directions. | Heliyon | 2024 | https://conductscience.org/library/papers/38434086 | PubMed |
| 38,151,648 | Dysregulation of histone deacetylases in ocular diseases. | Arch Pharm Res | 2024 | https://conductscience.org/library/papers/38151648 | PubMed |
| 37,627,114 | Dissecting Microbiome-Derived SCFAs in Prostate Cancer: Analyzing Gut Microbiota, Racial Disparities, and Epigenetic Mechanisms. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37627114 | PubMed |
| 37,390,973 | Therapeutically targeting the consequences of HIV-1-associated gastrointestinal dysbiosis: Implications for neurocognitive and affective alterations. | Pharmacol Biochem Behav | 2023 | https://conductscience.org/library/papers/37390973 | PubMed |
| 37,296,111 | Modulation of bone remodeling by the gut microbiota: a new therapy for osteoporosis. | Bone Res | 2023 | https://conductscience.org/library/papers/37296111 | PubMed |
| 37,175,583 | The Role of Histone Deacetylases in Acute Lung Injury-Friend or Foe. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37175583 | PubMed |
| 36,968,465 | Temperature-induced reactivation of Marek's disease virus-transformed T cells ex vivo. | Front Vet Sci | 2023 | https://conductscience.org/library/papers/36968465 | PubMed |
| 36,614,027 | Development of Human Adrenocortical Adenoma (HAA1) Cell Line from Zona Reticularis. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36614027 | PubMed |
| 36,402,792 | Gut microbiota analysis for prediction of clinical relapse in Crohn's disease. | Sci Rep | 2022 | https://conductscience.org/library/papers/36402792 | PubMed |
| 36,301,501 | Metabolic Regulation of Lysine Acetylation: Implications in Cancer. | Subcell Biochem | 2022 | https://conductscience.org/library/papers/36301501 | PubMed |
| 36,139,015 | Butyrate Induces Modifications of the CTCF-Binding Landscape in Cattle Cells. | Biomolecules | 2022 | https://conductscience.org/library/papers/36139015 | PubMed |
| 36,034,650 | Potential of histone deacetylase inhibitors in the control and regulation of prostate, breast and ovarian cancer. | Front Chem | 2022 | https://conductscience.org/library/papers/36034650 | PubMed |
| 35,867,577 | Panobinostat enhances NK cell cytotoxicity in soft tissue sarcoma. | Clin Exp Immunol | 2022 | https://conductscience.org/library/papers/35867577 | PubMed |
| 35,626,691 | Nicotinamide Mononucleotide Administration Amends Protein Acetylome of Aged Mouse Liver. | Cells | 2022 | https://conductscience.org/library/papers/35626691 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/268489
GET https://conductscience.org/api/papers/v1/268489/cited_by?page=2